Effective dose of intravenous oxycodone depending on sex and age for attenuation of intubation-related hemodynamic responses

Effective dose of intravenous oxycodone depending on sex and age for attenuation of intubation-related hemodynamic responses

Background/aim: Preoperative intravenous oxycodone may help to prevent or attenuate intubation-related hemodynamic responses (IRHRs), but its pharmacokinetics differs according to age and sex. Therefore, we investigated the 95% effective dose (ED95) of intravenous oxycodone for attenuating all IRHRs, depending on the age and sex of the study population. Materials and methods: All patients were allocated to one of 6 groups: 1) 20–40 year old males, 2) 41–65yearold males, 3) 66–80 year old males, 4) 20–40 year old females, 5) 41–65yearold females, and 6) 66–80 year old females (groups YM, OM, EM, YF, OF, and EF, respectively). Using Dixon’s up-and-down method, the first patient in each group was slowly injected with intravenous oxycodone (0.1 mg kg–1) 20 min before intubation. The subsequent patient received the next oxycodone dose, which was decreased or increased by 0.01 mg kg–1, depending on the “success” or “failure” of attenuation of all IRHRs to within 20% of the baseline values at 1 min after intubation in the previous patient. After obtaining 8 crossover points, predictive ED95 was estimated with probit regression analysis. Results: ED95 varied greatly according to age and sex. ED95was 0.133 mg kg–1, 0.181 mg kg–1, 0.332 mg kg–1, 0.183 mg kg–1, 0.108 mg kg–1, and 0.147 mg kg–1in groups YM, OM, EM, YF, OF, and EF, respectively. Conclusion: ED95 is higher in males with increasing age but is ambiguous for females. ED95 is higher in males than in females over 40 years of age but is higher in females than in males under 41 years of age. However, after considering the age and sex of the study population, these results can be used as reference doses for further studies to verify the clinical effects of oxycodone for attenuating all IRHRs.Key words: Hemodynamics, humans, intravenous administration, intubation, laryngoscopy, oxycodone

___

  • 1. Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database of Systematic Reviews 2013; (7): CD004087. doi: 10.1002/14651858.CD004087.pub2
  • 2. Hilliard PE, Waljee J, Moser S, Metz L, Mathis M et al. Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgery. JAMA Surgery 2018; 153 (10): 929-937. doi: 10.1001/jamasurg.2018.2102
  • 3. Fanelli G, Ghisi D, Berti M, Troglio R, Ortu A et al. Preoperative administration of controlled-release oxycodone as a transition opioid for total intravenous anaesthesia in pain control after laparoscopic cholecystectomy. Surgical Endoscopy 2008; 22 (10): 2220-2228. doi: 10.1007/s00464-008-0026-6
  • 4. Wang J, Fu Y, Ma H, Wang N. Effect of preoperative intravenous oxycodone after transurethral resection of prostate under general anesthesia. International Surgery 2018; 102 (7-8): 377- 381. doi: 10.9738/intsurg-d-15-00087.1
  • 5. Wang N, Wang Y, Pang L, Wang J. Effect of preemptive analgesia with intravenous oxycodone in the patients undergoing laparoscopic resection of ovarian tumor. Pakistan Journal of Medical Sciences 2015; 31 (2): 300-303. doi: 10.12669/ pjms.312.6686
  • 6. Park YH, Lee SH, Lee OH, Kang H, Shin HY et al. Optimal dose of intravenous oxycodone for attenuating hemodynamic changes after endotracheal intubation in healthy patients: a randomized controlled trial. Medicine (Baltimore) 2017; 96 (11): e6234. doi: 10.1097/md.0000000000006234
  • 7. Park KB, Ann J, Lee H. Effects of different dosages of oxycodone and fentanyl on the hemodynamic changes during intubation. Saudi Medical Journal 2016; 37 (8): 847-852. doi: 10.15537/ smj.2016.8.14822
  • 8. Lee YS, Baek CW, Kim DR, Kang H, Choi GJ et al. Comparison of hemodynamic response to tracheal intubation and postoperative pain in patients undergoing closed reduction of nasal bone fracture under general anesthesia: a randomized controlled trial comparing fentanyl and oxycodone. BMC Anesthesiology 2016; 16 (1): 115. doi: 10.1186/s12871-016-0279-x
  • 9. Kang XH, Bao FP, Zhang HG, Yu DJ, Ha K et al. Gender affects the median effective dose and 95% effective dose of oxycodone for blunting the hemodynamic response to tracheal intubation in narcotic-naive adult patients. Chinese Medical Journal 2018; 131 (16): 1958-1963. doi: 10.4103/0366-6999.238138
  • 10. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M et al. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups. Drugs & Aging 2011; 28 (1): 41-50. doi: 10.2165/11586140-000000000-00000
  • 11. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundstrom S et al. Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients. European Journal of Clinical Pharmacology 2011; 67 (5): 493- 506. doi: 10.1007/s00228-010-0948-5
  • 12. Koh GH, Jung KT, So KY, Seo JS, Kim SH. Effect of different doses of intravenous oxycodone and fentanyl on intubation-related hemodynamic responses: a prospective double-blind randomized controlled trial (CONSORT). Medicine (Baltimore) 2019; 98 (18): e15509. doi: 10.1097/ md.0000000000015509
  • 13. Dixon WJ. Efficient analysis of experimental observations. Annual Review of Pharmacology and Toxicology 1980; 20: 441-462. doi: 10.1146/annurev.pa.20.040180.002301
  • 14. Sawano Y, Miyazaki M, Shimada H, Kadoi Y. Optimal fentanyl dosage for attenuating systemic hemodynamic changes, hormone release and cardiac output changes during the induction of anesthesia in patients with and without hypertension: a prospective, randomized, double-blinded study. Journal of Anesthesia 2013; 27 (4): 505-511. doi: 10.1007/s00540-012-1552-x
  • 15. Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Neuvonen M et al. Plasma concentrations of oral oxycodone are greatly increased in the elderly. Clinical Pharmacology & Therapeutics 2008; 84 (4): 462-467. doi: 10.1038/clpt.2008.64
  • 16. Kumar A, Tyagi A. Dixon and Massey’s method: the starting dose. Anesthesia & Analgesia 2009; 108 (1): 378. doi: 10.1213/ ane.0b013e31818d4aa9
  • 17. Low JM, Harvey JT, Prys-Roberts C, Dagnino J. Studies of anaesthesia in relation to hypertension: VII: adrenergic responses to laryngoscopy. British Journal of Anaesthesia 1986; 58 (5): 471-477. doi: 10.1093/bja/58.5.471
  • 18. Sener EB, Ustun E, Ustun B, Sarihasan B. Hemodynamic responses and upper airway morbidity following tracheal intubation in patients with hypertension: conventional laryngoscopy versus an intubating laryngeal mask airway. Clinics 2012; 67 (1): 49-54. doi: 10.6061/clinics/2012(01)08
  • 19. Nishikawa K, Omote K, Kawana S, Namiki A. A comparison of hemodynamic changes after endotracheal intubation by using the lightwand device and the laryngoscope in normotensive and hypertensive patients. Anesthesia & Analgesia 2000; 90 (5): 1203-1207. doi: 10.1097/00000539-200005000-00038
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Perspectives for immune plasma treatment of COVID-19

Olgu Erkin ÇINAR, Başak SAYINALP, İbrahim Celalettin HAZNEDAROĞLU

Stereological and histopathological evaluation of the effect of Thymoquinone on peridural fibrosis following laminectomy in rats

Dursun TÜRKÖZ, Mehmet Emin ÖNGER, Aytaç TÜRKÖZ, Enis KURUOĞLU

Projecting the course of COVID-19 in Turkey: A probabilistic modeling approach

Seher Nur SÜLKÜ, Aybar C. ACAR, Hüseyin Cahit BURDUROĞLU, Yeşim AYDIN SON, Levent AKIN, Serhat ÜNAL, Ahmet Görkem ER

Lateral frontal galeal-cutaneous flap for reconstruction after orbital exenteration for advanced periorbital skin cancer

Predrag KOVACEVIC, Jasmina DJORDJEVIC-JOCIC, Milan RADOJKOVIC

Placement of hemodialysis catheters with the help of the micropuncture technique in patients with central venous occlusion and limited access

Erdem BİRGİ, Hasanali DURMAZ

Continuous renal replacement therapy in critically ill children: single-center experience

Emel OKULU, Tanıl KENDİRLİ, Begüm ATASAY, Mesiha EKİM, Hatice ERKOL TUNCER

Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

Levent KILIÇ, Emre BİLGİN, Ali AKDOĞAN, Umut KALYONCU, Sedat KİRAZ, Ömer KARADAĞ, Ali İhsan ERTENLİ, Gözde Kübra YARDIMCI, Emine DURAN, , Ertuğrul Çağrı BÖLEK, Furkan CEYLAN, Bayram FARİSOĞULLARI, Şule Apraş BİLGEN

The evaluation of intracellular energy metabolism in prediabetic patients and patients newly diagnosed with type 2 diabetes mellitus

Hüseyin ÖZDEN, Erkan DULKADİROĞLU, Hüseyin DEMİRCİ

Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients

Yeşim SÜCÜLLÜ KARADAĞ, Tankut KÖSEOĞLU, Emin ALTIPARMAK, Ömer ÖZTÜRK, Tuğçe SALTOĞLU, Fadime ERDOĞAN KÜÇÜKDAĞLI

Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis

Levent KILIÇ, Abdulsamet ERDEN, Ayşe Bahar KELEŞOĞLU DİNÇER, Umut KALYONCU, Sedat KİRAZ, Ömer KARADAĞ, Tuncay HAZIROLAN